Key points are not available for this paper at this time.
Aim: Polymeric nanoparticles (NPs) cloaked by red blood cell membrane (RBCm) confer the combined advantage of both long circulation lifetime and controlled drug release. The authors carried out studies to gain a better understanding of the drug loading, drug-release kinetics and cell-based efficacy of RBCm-cloaked NPs. Materials Revised submitted 27 August 2012; Published online 14 February 2013
Aryal et al. (Thu,) studied this question.